<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/B1D8BA81-1560-4AE3-B05E-0DD995994849"><gtr:id>B1D8BA81-1560-4AE3-B05E-0DD995994849</gtr:id><gtr:name>Process Systems Enterprise Limited</gtr:name><gtr:address><gtr:line1>5th Floor East, 26-28
Hammersmith Grove</gtr:line1><gtr:city>London</gtr:city><gtr:postCode>W6 7HA</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>P</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B1D8BA81-1560-4AE3-B05E-0DD995994849" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>B1D8BA81-1560-4AE3-B05E-0DD995994849</gtr:id><gtr:name>Process Systems Enterprise Limited</gtr:name><gtr:address><gtr:line1>5th Floor East, 26-28
Hammersmith Grove</gtr:line1><gtr:city>London</gtr:city><gtr:postCode>W6 7HA</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_PARTICIPANT</gtr:name></gtr:role><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>443597.0</gtr:offerGrant><gtr:projectCost>739329.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/88D9B098-A8B2-4361-8E8C-2E20929B2A47" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>88D9B098-A8B2-4361-8E8C-2E20929B2A47</gtr:id><gtr:name>Britest Limited</gtr:name><gtr:address><gtr:line1>9400 GARSINGTON ROAD , OXFORD BUSINESS PARK</gtr:line1><gtr:city>OXFORD</gtr:city><gtr:postCode>OX4 2HN</gtr:postCode><gtr:region>South East</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>75298.0</gtr:offerGrant><gtr:projectCost>125497.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CAD50556-5BDA-48CD-B70E-4BDEB44C52E3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>CAD50556-5BDA-48CD-B70E-4BDEB44C52E3</gtr:id><gtr:name>AstraZeneca UK Limited</gtr:name><gtr:address><gtr:line1>15 Stanhope Gate</gtr:line1><gtr:city>Westminster</gtr:city><gtr:postCode>W1K 1LN</gtr:postCode><gtr:region>North West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>31236.0</gtr:offerGrant><gtr:projectCost>62472.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C84B5752-9865-4D3A-897C-12212C1EE663" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>C84B5752-9865-4D3A-897C-12212C1EE663</gtr:id><gtr:name>Pfizer Limited</gtr:name><gtr:address><gtr:line1>PFIZER LIMITED, RAMSGATE ROAD , SANDWICH</gtr:line1><gtr:city>KENT</gtr:city><gtr:postCode>CT13 9NJ</gtr:postCode><gtr:region>South East</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>0.0</gtr:offerGrant><gtr:projectCost>0.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F5B045CA-D95F-469C-86A9-00BEB9AC600E" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>F5B045CA-D95F-469C-86A9-00BEB9AC600E</gtr:id><gtr:name>Glaxosmithkline Services Unlimited</gtr:name><gtr:address><gtr:line1>980 GREAT WEST ROAD , BRENTFORD</gtr:line1><gtr:city>MIDDLESEX</gtr:city><gtr:postCode>TW8 9GS</gtr:postCode><gtr:region>South East</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>30204.0</gtr:offerGrant><gtr:projectCost>60408.0</gtr:projectCost></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/D69F6460-A28A-4D1F-886E-25B2F170ADEA"><gtr:id>D69F6460-A28A-4D1F-886E-25B2F170ADEA</gtr:id><gtr:firstName>Manisha</gtr:firstName><gtr:surname>Tayal</gtr:surname><gtr:roles><gtr:role><gtr:name>PROJECT_MANAGER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=101720"><gtr:id>7AF21918-3F9C-4A73-9D0E-769CA4C7CDAB</gtr:id><gtr:title>Digital Design of Drug Products</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Collaborative R&amp;D</gtr:grantCategory><gtr:grantReference>101720</gtr:grantReference><gtr:abstractText>This project brings together experts in drug development, product formulation, process design, systems modelling and manufacture to create a completely new approach to the design and manufacture of formulated drug products, which involves the integration of qualitative tools for process understanding with a range of in-silico models which describe and predict processing and product performance. It is anticipated that successful outcomes of digital design of drug formulations as envisaged in this proposal via the creation of ?Design Space Explorer? will provide unparalleled improvements in reliability, quality and manufacturing processes of pharmaceutical products leading to greater trust by regulatory agencies and by society. Furthermore it is anticipated that a successful outcome to the proposed project has potential to significantly decrease the costs and times associated with the development of new medicines whilst also reducing, refining and and at times removing the need for some clinical studies in patients and healthy volunteers.</gtr:abstractText><gtr:fund><gtr:end>2016-05-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/E18E2F0F-AC7D-4E02-9559-669F7C8FEC74"><gtr:id>E18E2F0F-AC7D-4E02-9559-669F7C8FEC74</gtr:id><gtr:name>Innovate UK</gtr:name></gtr:funder><gtr:start>2014-06-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>580335</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">101720</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>